跳至主要内容
临床试验/NCT01693289
NCT01693289已完成1 期

Phase 1 Study of Efficacy of Combined Metformin-letrozole in Comparison With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian Syndrome

Zagazig University1 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
146
试验地点
1
主要终点
hormonal and metabolic changes

研究概览

简要总结

the study compare the hormonal-metabolic and reproductive outcome between combined metformin-letrozole and ovarian drilling in clomiphene resistant women with polycystic syndrome

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • polycystic ovary syndrome
  • infertility
  • clomiphene citrate resistance

排除标准

  • women with other causes of infertility as male factor or tubal factor, those with endocrine disorders as thyroid dysfunction and hyperprolactinemia women who received hormonal treatment or ovulation induction drugs 3 months prior to the study
  • pregnancy during follow up

研究组 & 干预措施

Metformin plus letrozole

Experimental

metformin :850mg tablets twice daily for 6 months letrozole :5mg tablets twice daily form day 3to7 of cycle

干预措施: metformin plus letrozole (Drug)

ovarian drilling

Experimental

bilateral diathermy ovarian drilling, four drills each ovary

干预措施: ovarian drilling (Procedure)

结局指标

主要结局

hormonal and metabolic changes

时间窗: 6 months

次要结局

  • reproductive outcome(6months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

IBRAHIM ABD ELGAFOR

obstetrics and gynecology department

Zagazig University

研究点 (1)

Loading locations...

相似试验